Literature DB >> 30741766

Adjuvant Chemotherapy for Colon Cancer.

Richard S Hoehn1, J Joshua Smith2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30741766      PMCID： PMC6432933          DOI： 10.1097/DCR.0000000000001328

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN： 0012-3706            Impact factor:   4.585


× No keyword cloud information.
  8 in total

1.  Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.

Authors:  Aimery de Gramont; Eric Van Cutsem; Hans-Joachim Schmoll; Josep Tabernero; Stephen Clarke; Malcolm J Moore; David Cunningham; Thomas H Cartwright; J Randolph Hecht; Fernando Rivera; Seock-Ah Im; György Bodoky; Ramon Salazar; Frédérique Maindrault-Goebel; Einat Shacham-Shmueli; Emilio Bajetta; Martina Makrutzki; Aijing Shang; Thierry André; Paulo M Hoff
Journal:  Lancet Oncol       Date:  2012-11-16       Impact factor: 41.316

2.  Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators.

Authors: 
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

3.  Capecitabine as adjuvant treatment for stage III colon cancer.

Authors:  Chris Twelves; Alfred Wong; Marek P Nowacki; Markus Abt; Howard Burris; Alfredo Carrato; Jim Cassidy; Andrés Cervantes; Jan Fagerberg; Vassilis Georgoulias; Fares Husseini; Duncan Jodrell; Piotr Koralewski; Hendrik Kröning; Jean Maroun; Norbert Marschner; Joseph McKendrick; Marek Pawlicki; Riccardo Rosso; Johannes Schüller; Jean-François Seitz; Borut Stabuc; Jerzy Tujakowski; Guy Van Hazel; Jerzy Zaluski; Werner Scheithauer
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

4.  Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Authors:  J Philip Kuebler; H Samuel Wieand; Michael J O'Connell; Roy E Smith; Linda H Colangelo; Greg Yothers; Nicholas J Petrelli; Michael P Findlay; Thomas E Seay; James N Atkins; John L Zapas; J Wendall Goodwin; Louis Fehrenbacher; Ramesh K Ramanathan; Barbara A Conley; Patrick J Flynn; Gamini Soori; Lauren K Colman; Edward A Levine; Keith S Lanier; Norman Wolmark
Journal:  J Clin Oncol       Date:  2007-04-30       Impact factor: 44.544

5.  Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Authors:  Thierry André; Corrado Boni; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Andrea Bonetti; Philip Clingan; John Bridgewater; Fernando Rivera; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

6.  Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Authors:  Leonard B Saltz; Donna Niedzwiecki; Donna Hollis; Richard M Goldberg; Alexander Hantel; James P Thomas; Anthony L A Fields; Robert J Mayer
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

7.  Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

Authors:  Thierry André; Armand de Gramont; Dewi Vernerey; Benoist Chibaudel; Franck Bonnetain; Annemilaï Tijeras-Raballand; Aurelie Scriva; Tamas Hickish; Josep Tabernero; Jean Luc Van Laethem; Maria Banzi; Eduard Maartense; Einat Shmueli; Goran U Carlsson; Werner Scheithauer; Demetris Papamichael; Marcus Möehler; Stefania Landolfi; Pieter Demetter; Soudhir Colote; Christophe Tournigand; Christophe Louvet; Alex Duval; Jean-François Fléjou; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

8.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Authors:  Richard Gray; Jennifer Barnwell; Christopher McConkey; Robert K Hills; Norman S Williams; David J Kerr
Journal:  Lancet       Date:  2007-12-15       Impact factor: 79.321
  8 in total
  2 in total

1.  Optimal adjuvant chemotherapy completion time for stage III colon cancer: a cohort study.

Authors:  Jing-Qing Ren; Han-Shuo Zhang; Li-Hua Zhang; Qi-Guang Zhong; Fan Wu; Bai-Lin Wang; Shao-Jie Liu
Journal:  J Gastrointest Oncol       Date:  2021-08

Review 2.  Colon Cancer Pharmacogenetics: A Narrative Review.

Authors:  Álvaro Esteban Alfaro Alfaro; Brayan Murillo Castillo; Eugenia Cordero García; Javier Tascón; Ana I Morales
Journal:  Pharmacy (Basel)       Date:  2022-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.